News About: Pharm. Industry
Some pharmaceutical firms won injunction trial on suspension of drug prices' reduction
In a recent ruling of an injunction trial raised by some pharmaceutical firms against the Ministry of Health and Welfare, a Seoul administrative court made a ruling in favor of Pharmacia Korea and Hanyoung Pharm, to t...
Cheiljedang opened multi-healthcare shop at Cheongdam Seoul.
Cheiljedang CJ Neutra has opened "Health Multishop", a 3 storied and large scale of mart specialized for health food supplements for the first time in Korea at Cheongdam dong in Seoul.
The shop displayed about 40...
Discount on credit collection deemed it normal deals.
The KPMA filed an inquiry to the government for the legal interpretation of the discounts on credit collection in viewing it a normal commercial practice, and claimed that such discounts practice should be excluded fr...
Dongshin Pharm to recall imported oral BCG vaccines
Following the August 13 report of Reuters News Agency that Powderject Pharmaceuticals Plc in the U.K. voluntarily recalled BCG (tuberculosis) vaccines due to a small number of batches which did not meet the end-of-she...
Total pharmaceuticals produced last year at 1.55% of GDP.
The share of pharmaceutical production vs. GDP last year was 1.55%, showing a slight slow compared with the previous year probably due to depressed OTC market after the implementation of the medical and pharma...
SMAB unveils plan to foster 500 promising venture firms
The Small and Medium Business Administration (SMBA) recently unveiled a plan to provide various supports to promising venture firms in an effort to expedite their advancement into overseas markets.
The SMBA will se...
Diet supplements business sharply depressed due to toxicity scandals.
The diet supplement product business has been drastically plunged as the toxic problems bursted out in the imported diet supplement products, which was detected and reported by the KFDA especially among the products s...
Frequently sold OTCs show no significant pricing difference
The regional Korea Food and Drug Administration in Seoul said that its pricing survey of 30 pharmacies in Seoul conducted from April to June this year disclosed that the pricing differences of frequently sold ...
KPMA proposes to institutionalize ex post facto drug management rules
The Korea Pharmaceutical Manufacturers Association (KPMA) said it would propose its ex post facto drug management rules to the government, to this effect that the minimum drug-pricing system should be applied to the d...
Questions arise over reference pricing system
Although the government reiterated the reference pricing system (RPS) will prevent the abuse of high-priced drugs and bring about a reduction in insurance cost, the pharmaceutical firms and civil groups oppose the pla...
